Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

Fig. 2

Overall survival (OS) for risk groups defined by four prognostic models in the validation cohort (n = 297). a OS stratified by the new model; (b) OS stratified by the International Prognostic Index (IPI); (c) OS stratified by the revised IPI (R-IPI); (d) OS stratified by the National Comprehensive Cancer Network- IPI (NCCN-IPI)

Back to article page